Antibodies against HDL components improve the diagnostic accuracy between ischemic stroke or coronary artery disease and healthy controls when added to traditional cardiovascular risk factors

This study aims to investigate whether these antibodies had additional value to traditional CV risk factors for the diagnosis of IS and CAD.

Source: Atherosclerosis - August 1, 2018 Category: Cardiology Authors: J. Batuca, M. Amaral, C. Favas, G. Justino, A. Papoila, P. Ames, J. Delgado Alves Source Type: research